Der Kaninchen Polyklonal Anti-Factor VII-Antikörper wurde für WB und IHC validiert. Er ist geeignet, Factor VII in Proben von Human und Maus zu detektieren.
Produktnummer ABIN1886186
Kurzübersicht für Factor VII Antikörper (AA 209-444) (ABIN1886186)
F7
Reaktivität: Human
WB, ELISA
Wirt: Maus
Polyclonal
unconjugated
Applikationshinweise
Suggested dilutions: Western blotting: 1.500-1.3000 Immunohistochemistry: 1.100-1.250
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Buffer
0.1 M Tris-buffered saline with 10 % Glycerol (pH 7.0).0.01 % Thimerosal was added as a preservative.
Konservierungsmittel
Thimerosal (Merthiolate)
Vorsichtsmaßnahmen
Biohazard Informations: This product contains thimerosal which is hazardous.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store at -20 °C for long term preservation (recommended). Store at 4 °C for short term use.
Target
Factor VII (F7)
(Coagulation Factor VII (F7))
Andere Bezeichnung
Factor VII
Hintergrund
This gene encodes coagulation factor VII which is a vitamin K-dependent factor essential for hemostasis.This factor circulates in the blood in a zymogen form, and is converted to an active form by either factor IXa, factor Xa, factor XIIa, or thrombin by minor proteolysis.Upon activation of the factor VII, a heavy chain containing a catalytic domain and a light chain containing 2 EGF-like domains are generated, and two chains are held together by a disulfide bond.In the presence of factor III and calcium ions, the activated factor then further activates the coagulation cascade by converting factor IX to factor IXa and/or factor X to factor Xa.Alternative splicing of this gene results in 2 transcripts.Defects in this gene can cause coagulopathy.[provided by RefSeq]